BIOREM Inc.
BRM.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.34% | -11.89% | 39.06% | 705.12% | 278.93% |
| Total Depreciation and Amortization | 40.50% | 38.76% | 21.93% | 111.52% | 22.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.87% | -45.13% | -7.06% | 13,919.79% | 4,121.26% |
| Change in Net Operating Assets | 287.40% | 135.13% | 87.09% | -190.82% | 94.59% |
| Cash from Operations | -7.80% | 8.14% | 665.61% | 72.18% | 514.69% |
| Capital Expenditure | 31.94% | 88.96% | 33.18% | 66.41% | 9.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 31.94% | 88.96% | 33.18% | 66.41% | 9.28% |
| Total Debt Issued | -- | -- | -- | -- | -200.00% |
| Total Debt Repaid | 50.32% | 51.34% | 47.86% | 53.51% | -56.32% |
| Issuance of Common Stock | -- | -- | 127.39% | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 69.95% | 67.41% | 57.43% | 51.85% | -258.94% |
| Foreign Exchange rate Adjustments | 66.37% | 781.54% | 310.11% | 119.22% | 50.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.80% | 191.58% | 300.18% | 508.27% | 185.48% |